GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Royce Micro-Cap Trust Inc (NYSE:RMT) » Definitions » Research & Development

Royce Micro-Cap Trust (Royce Micro-Cap Trust) Research & Development

: $0.00 Mil (TTM As of Dec. 2023)
View and export this data going back to 2003. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Royce Micro-Cap Trust's Research & Development for the six months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


Royce Micro-Cap Trust Research & Development Historical Data

The historical data trend for Royce Micro-Cap Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Royce Micro-Cap Trust Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Premium Member Only Premium Member Only - - - - -

Royce Micro-Cap Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Royce Micro-Cap Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Royce Micro-Cap Trust  (NYSE:RMT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Royce Micro-Cap Trust Research & Development Related Terms

Thank you for viewing the detailed overview of Royce Micro-Cap Trust's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Royce Micro-Cap Trust (Royce Micro-Cap Trust) Business Description

Traded in Other Exchanges
N/A
Address
745 Fifth Avenue, New York, NY, USA, 10151
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparel, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
Executives
Julia Ward Poston director C/O ROYCE & ASSOCIATES, 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151
Christopher C. Grisanti director 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151
O Byrne Daniel A officer: Vice President, other: VP - Investment Advisor ROYCE & ASSOCIATES, 745 FIFTH AVENUE, NEW YORK NY 10151
G Peter Obrien director C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151
Michael K. Shields director C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151
Christopher D Clark officer: Vice President, other: President - Investment Advisor 745 FIFTH AVENUE, SUITE 2400, NEW YORK NY 10151
Cecile Burleigh Harper director C/O ROYCE & ASSOCIATES, 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151
Charles M Royce director, officer: President, other: President-Investment Adviser C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151
John E Denneen officer: Secretary, other: Secretary-Investment Adviser C/O ROYCE & ASSOCIATES LLC, 745 FIFTH AVENUE, NEW YORK NY 10151
Richard M Galkin director, other: Director through 2/26/2016. C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151
Arthur S Mehlman director C/O ROYCE & ASSOCIATES, 745 FIFTH AVENUE, NEW YORK NY 10151
John D Diederich officer: Vice President & Treasurer, other: COO & CFO - Investment Adviser ROYCE & ASSOCIATES LLC, 745 FIFTH AVENUE, NEW YORK NY 10151
Peter K Hoglund officer: Treasuer, other: CFO Investment Advisor 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151
W Whitney George director, officer: Vice President, other: VP-Royce, through 11/10/2014 C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151
Fockler Jack E. Jr. officer: Vice President, other: VP - Investment Advisor C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151